CA2689131A1 - La nouvelle adipocytokine visfatine/pbef1 est un facteur associe a l'apoptose induit dans les monocytes pendant une infection du vih-i in vivo - Google Patents

La nouvelle adipocytokine visfatine/pbef1 est un facteur associe a l'apoptose induit dans les monocytes pendant une infection du vih-i in vivo Download PDF

Info

Publication number: CA2689131A1
Authority: CA; Canada
Prior art keywords: hiv; pbef1; expression; infection; monocytes
Prior art date: 2007-06-08
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

CA002689131A

Other languages

English (en)

Inventor

Geert Raes

Patrick De Baetselier

Rafael Van Den Bergh

Guido Vanham

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

INSTITUUT VOOR TROPISCHE GENEESKUNDE

Vlaams Instituut voor Biotechnologie VIB

Vrije Universiteit Brussel VUB

Original Assignee

Individual

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2007-06-08

Filing date

2008-06-05

Publication date

2008-12-11

2008-06-05 Application filed by Individual filed Critical Individual

2008-12-11 Publication of CA2689131A1 publication Critical patent/CA2689131A1/fr

Status Abandoned legal-status Critical Current

Links

210000001616 monocyte Anatomy 0.000 title claims abstract description 70
208000031886 HIV Infections Diseases 0.000 title abstract description 31
108010064862 Nicotinamide phosphoribosyltransferase Proteins 0.000 title description 39
230000006907 apoptotic process Effects 0.000 title description 15
238000001727 in vivo Methods 0.000 title description 6
102000014777 Adipokines Human genes 0.000 title description 5
108010078606 Adipokines Proteins 0.000 title description 5
102000015532 Nicotinamide phosphoribosyltransferase Human genes 0.000 title description 5
102100033223 Nicotinamide phosphoribosyltransferase Human genes 0.000 claims abstract description 97
230000014509 gene expression Effects 0.000 claims abstract description 71
101000998855 Homo sapiens Nicotinamide phosphoribosyltransferase Proteins 0.000 claims abstract description 67
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims abstract description 31
201000010099 disease Diseases 0.000 claims abstract description 26
238000000034 method Methods 0.000 claims abstract description 26
238000002955 isolation Methods 0.000 claims abstract description 6
208000011580 syndromic disease Diseases 0.000 claims abstract description 6
210000004369 blood Anatomy 0.000 claims description 14
239000008280 blood Substances 0.000 claims description 14
206010065042 Immune reconstitution inflammatory syndrome Diseases 0.000 claims description 11
208000030507 AIDS Diseases 0.000 claims description 8
206010012289 Dementia Diseases 0.000 claims description 6
206010049287 Lipodystrophy acquired Diseases 0.000 claims description 5
238000003745 diagnosis Methods 0.000 claims description 5
208000006132 lipodystrophy Diseases 0.000 claims description 5
108020004999 messenger RNA Proteins 0.000 claims description 3
238000004393 prognosis Methods 0.000 claims description 3
238000005259 measurement Methods 0.000 claims 1
208000037357 HIV infectious disease Diseases 0.000 abstract description 26
208000033519 human immunodeficiency virus infectious disease Diseases 0.000 abstract description 26
238000011282 treatment Methods 0.000 abstract description 9
108090000623 proteins and genes Proteins 0.000 description 67
241000725303 Human immunodeficiency virus Species 0.000 description 44
210000004027 cell Anatomy 0.000 description 40
230000003612 virological effect Effects 0.000 description 30
241000700605 Viruses Species 0.000 description 27
210000002540 macrophage Anatomy 0.000 description 25
238000004458 analytical method Methods 0.000 description 21
208000015181 infectious disease Diseases 0.000 description 20
230000037361 pathway Effects 0.000 description 20
210000001744 T-lymphocyte Anatomy 0.000 description 16
230000004913 activation Effects 0.000 description 15
239000003550 marker Substances 0.000 description 14
230000000694 effects Effects 0.000 description 13
238000002474 experimental method Methods 0.000 description 12
210000003819 peripheral blood mononuclear cell Anatomy 0.000 description 12
210000004980 monocyte derived macrophage Anatomy 0.000 description 11
238000002560 therapeutic procedure Methods 0.000 description 11
108010044012 STAT1 Transcription Factor Proteins 0.000 description 9
102000006381 STAT1 Transcription Factor Human genes 0.000 description 9
238000000338 in vitro Methods 0.000 description 9
239000012528 membrane Substances 0.000 description 9
230000008569 process Effects 0.000 description 9
108020004445 glyceraldehyde-3-phosphate dehydrogenase Proteins 0.000 description 8
102000004169 proteins and genes Human genes 0.000 description 8
101710205625 Capsid protein p24 Proteins 0.000 description 7
101710177166 Phosphoprotein Proteins 0.000 description 7
101710149279 Small delta antigen Proteins 0.000 description 7
102100022563 Tubulin polymerization-promoting protein Human genes 0.000 description 7
230000006870 function Effects 0.000 description 7
IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 6
238000002965 ELISA Methods 0.000 description 6
102100031181 Glyceraldehyde-3-phosphate dehydrogenase Human genes 0.000 description 6
241000713772 Human immunodeficiency virus 1 Species 0.000 description 6
108010029485 Protein Isoforms Proteins 0.000 description 6
102000001708 Protein Isoforms Human genes 0.000 description 6
206010051259 Therapy naive Diseases 0.000 description 6
230000004064 dysfunction Effects 0.000 description 6
230000006698 induction Effects 0.000 description 6
NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 6
210000004698 lymphocyte Anatomy 0.000 description 6
230000019491 signal transduction Effects 0.000 description 6
230000011664 signaling Effects 0.000 description 6
102000004127 Cytokines Human genes 0.000 description 5
108090000695 Cytokines Proteins 0.000 description 5
102100029145 DNA damage-inducible transcript 3 protein Human genes 0.000 description 5
108010021625 Immunoglobulin Fragments Proteins 0.000 description 5
102000008394 Immunoglobulin Fragments Human genes 0.000 description 5
238000000692 Student's t-test Methods 0.000 description 5
230000027455 binding Effects 0.000 description 5
239000002299 complementary DNA Substances 0.000 description 5
208000035475 disorder Diseases 0.000 description 5
230000037356 lipid metabolism Effects 0.000 description 5
239000013610 patient sample Substances 0.000 description 5
108091032973 (ribonucleotides)n+m Proteins 0.000 description 4
102000011727 Caspases Human genes 0.000 description 4
108010076667 Caspases Proteins 0.000 description 4
108700020134 Human immunodeficiency virus 1 nef Proteins 0.000 description 4
206010022489 Insulin Resistance Diseases 0.000 description 4
DAYLJWODMCOQEW-TURQNECASA-O NMN(+) Chemical compound NC(=O)C1=CC=C[N+]([C@H]2[C@@H]([C@H](O)[C@@H](COP(O)(O)=O)O2)O)=C1 DAYLJWODMCOQEW-TURQNECASA-O 0.000 description 4
108010057666 Transcription Factor CHOP Proteins 0.000 description 4
238000003491 array Methods 0.000 description 4
230000033228 biological regulation Effects 0.000 description 4
230000008859 change Effects 0.000 description 4
238000009396 hybridization Methods 0.000 description 4
230000002757 inflammatory effect Effects 0.000 description 4
239000003112 inhibitor Substances 0.000 description 4
239000003446 ligand Substances 0.000 description 4
230000000670 limiting effect Effects 0.000 description 4
230000001404 mediated effect Effects 0.000 description 4
238000010606 normalization Methods 0.000 description 4
239000000047 product Substances 0.000 description 4
102000005962 receptors Human genes 0.000 description 4
108020003175 receptors Proteins 0.000 description 4
230000009467 reduction Effects 0.000 description 4
230000002829 reductive effect Effects 0.000 description 4
230000001105 regulatory effect Effects 0.000 description 4
UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 4
238000012353 t test Methods 0.000 description 4
208000001072 type 2 diabetes mellitus Diseases 0.000 description 4
102100037135 BCL2/adenovirus E1B 19 kDa protein-interacting protein 2 Human genes 0.000 description 3
108091003079 Bovine Serum Albumin Proteins 0.000 description 3
102100031650 C-X-C chemokine receptor type 4 Human genes 0.000 description 3
102000019034 Chemokines Human genes 0.000 description 3
108010012236 Chemokines Proteins 0.000 description 3
108091026890 Coding region Proteins 0.000 description 3
108700039887 Essential Genes Proteins 0.000 description 3
101000740576 Homo sapiens BCL2/adenovirus E1B 19 kDa protein-interacting protein 2 Proteins 0.000 description 3
101000922348 Homo sapiens C-X-C chemokine receptor type 4 Proteins 0.000 description 3
102000004877 Insulin Human genes 0.000 description 3
108090001061 Insulin Proteins 0.000 description 3
108010002350 Interleukin-2 Proteins 0.000 description 3
102000000588 Interleukin-2 Human genes 0.000 description 3
108010047620 Phytohemagglutinins Proteins 0.000 description 3
102000007056 Recombinant Fusion Proteins Human genes 0.000 description 3
108010008281 Recombinant Fusion Proteins Proteins 0.000 description 3
108700008625 Reporter Genes Proteins 0.000 description 3
108010047933 Tumor Necrosis Factor alpha-Induced Protein 3 Proteins 0.000 description 3
102100024596 Tumor necrosis factor alpha-induced protein 3 Human genes 0.000 description 3
HAXFWIACAGNFHA-UHFFFAOYSA-N aldrithiol Chemical compound C=1C=CC=NC=1SSC1=CC=CC=N1 HAXFWIACAGNFHA-UHFFFAOYSA-N 0.000 description 3
230000002424 anti-apoptotic effect Effects 0.000 description 3
239000000427 antigen Substances 0.000 description 3
108091007433 antigens Proteins 0.000 description 3
102000036639 antigens Human genes 0.000 description 3
238000003556 assay Methods 0.000 description 3
238000011109 contamination Methods 0.000 description 3
230000000875 corresponding effect Effects 0.000 description 3
210000004443 dendritic cell Anatomy 0.000 description 3
238000001514 detection method Methods 0.000 description 3
230000002255 enzymatic effect Effects 0.000 description 3
230000009088 enzymatic function Effects 0.000 description 3
239000012634 fragment Substances 0.000 description 3
230000002458 infectious effect Effects 0.000 description 3
230000001524 infective effect Effects 0.000 description 3
229940125396 insulin Drugs 0.000 description 3
230000003993 interaction Effects 0.000 description 3
210000000265 leukocyte Anatomy 0.000 description 3
239000002609 medium Substances 0.000 description 3
238000002493 microarray Methods 0.000 description 3
230000001885 phytohemagglutinin Effects 0.000 description 3
239000000523 sample Substances 0.000 description 3
108010060263 Adenosine A1 Receptor Proteins 0.000 description 2
102000030814 Adenosine A1 receptor Human genes 0.000 description 2
102100021569 Apoptosis regulator Bcl-2 Human genes 0.000 description 2
108091012583 BCL2 Proteins 0.000 description 2
241000283690 Bos taurus Species 0.000 description 2
102100031151 C-C chemokine receptor type 2 Human genes 0.000 description 2
102100025248 C-X-C motif chemokine 10 Human genes 0.000 description 2
HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
101001002634 Homo sapiens Interleukin-1 alpha Proteins 0.000 description 2
101000611023 Homo sapiens Tumor necrosis factor receptor superfamily member 6 Proteins 0.000 description 2
101000850748 Homo sapiens Tumor necrosis factor receptor type 1-associated DEATH domain protein Proteins 0.000 description 2
206010061218 Inflammation Diseases 0.000 description 2
102100034343 Integrase Human genes 0.000 description 2
102100020881 Interleukin-1 alpha Human genes 0.000 description 2
102000009565 Lysosomal-Associated Membrane Protein 2 Human genes 0.000 description 2
108010009491 Lysosomal-Associated Membrane Protein 2 Proteins 0.000 description 2
102000043136 MAP kinase family Human genes 0.000 description 2
108091054455 MAP kinase family Proteins 0.000 description 2
108010046938 Macrophage Colony-Stimulating Factor Proteins 0.000 description 2
102100028123 Macrophage colony-stimulating factor 1 Human genes 0.000 description 2
BAWFJGJZGIEFAR-NNYOXOHSSA-O NAD(+) Chemical compound NC(=O)C1=CC=C[N+]([C@H]2[C@@H]([C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OC[C@@H]3[C@H]([C@@H](O)[C@@H](O3)N3C4=NC=NC(N)=C4N=C3)O)O2)O)=C1 BAWFJGJZGIEFAR-NNYOXOHSSA-O 0.000 description 2
229930182555 Penicillin Natural products 0.000 description 2
JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 2
102100028642 Prostaglandin E synthase 3 Human genes 0.000 description 2
101710149951 Protein Tat Proteins 0.000 description 2
238000002123 RNA extraction Methods 0.000 description 2
239000013614 RNA sample Substances 0.000 description 2
108010092799 RNA-directed DNA polymerase Proteins 0.000 description 2
239000012980 RPMI-1640 medium Substances 0.000 description 2
206010040047 Sepsis Diseases 0.000 description 2
108060008682 Tumor Necrosis Factor Proteins 0.000 description 2
108010080432 Tumor Necrosis Factor Receptor-Associated Peptides and Proteins Proteins 0.000 description 2
102000000160 Tumor Necrosis Factor Receptor-Associated Peptides and Proteins Human genes 0.000 description 2
102100040403 Tumor necrosis factor receptor superfamily member 6 Human genes 0.000 description 2
102100033081 Tumor necrosis factor receptor type 1-associated DEATH domain protein Human genes 0.000 description 2
230000001594 aberrant effect Effects 0.000 description 2
239000012190 activator Substances 0.000 description 2
239000000478 adipokine Substances 0.000 description 2
230000000840 anti-viral effect Effects 0.000 description 2
238000013459 approach Methods 0.000 description 2
238000003705 background correction Methods 0.000 description 2
239000000090 biomarker Substances 0.000 description 2
230000015572 biosynthetic process Effects 0.000 description 2
210000003169 central nervous system Anatomy 0.000 description 2
238000006243 chemical reaction Methods 0.000 description 2
230000001276 controlling effect Effects 0.000 description 2
230000002596 correlated effect Effects 0.000 description 2
230000007423 decrease Effects 0.000 description 2
230000001419 dependent effect Effects 0.000 description 2
206010012601 diabetes mellitus Diseases 0.000 description 2
229940079593 drug Drugs 0.000 description 2
239000003814 drug Substances 0.000 description 2
239000012894 fetal calf serum Substances 0.000 description 2
230000002068 genetic effect Effects 0.000 description 2
230000002779 inactivation Effects 0.000 description 2
230000004054 inflammatory process Effects 0.000 description 2
230000002401 inhibitory effect Effects 0.000 description 2
150000002632 lipids Chemical class 0.000 description 2
230000004879 molecular function Effects 0.000 description 2
210000000066 myeloid cell Anatomy 0.000 description 2
102000002574 p38 Mitogen-Activated Protein Kinases Human genes 0.000 description 2
108010068338 p38 Mitogen-Activated Protein Kinases Proteins 0.000 description 2
239000008188 pellet Substances 0.000 description 2
229940049954 penicillin Drugs 0.000 description 2
150000003904 phospholipids Chemical class 0.000 description 2
230000000770 proinflammatory effect Effects 0.000 description 2
238000003753 real-time PCR Methods 0.000 description 2
238000009877 rendering Methods 0.000 description 2
238000007619 statistical method Methods 0.000 description 2
229960005322 streptomycin Drugs 0.000 description 2
239000006228 supernatant Substances 0.000 description 2
230000008685 targeting Effects 0.000 description 2
238000012360 testing method Methods 0.000 description 2
230000001225 therapeutic effect Effects 0.000 description 2
238000013518 transcription Methods 0.000 description 2
230000035897 transcription Effects 0.000 description 2
230000003827 upregulation Effects 0.000 description 2
102100040685 14-3-3 protein zeta/delta Human genes 0.000 description 1
101150033839 4 gene Proteins 0.000 description 1
101150096316 5 gene Proteins 0.000 description 1
102100033346 Adenosine receptor A1 Human genes 0.000 description 1
108010087905 Adenovirus E1B Proteins Proteins 0.000 description 1
108010063104 Apoptosis Regulatory Proteins Proteins 0.000 description 1
102000010565 Apoptosis Regulatory Proteins Human genes 0.000 description 1
102100021631 B-cell lymphoma 6 protein Human genes 0.000 description 1
102100027314 Beta-2-microglobulin Human genes 0.000 description 1
102100031172 C-C chemokine receptor type 1 Human genes 0.000 description 1
101710149814 C-C chemokine receptor type 1 Proteins 0.000 description 1
101710149815 C-C chemokine receptor type 2 Proteins 0.000 description 1
102100035875 C-C chemokine receptor type 5 Human genes 0.000 description 1
101710149870 C-C chemokine receptor type 5 Proteins 0.000 description 1
101710098275 C-X-C motif chemokine 10 Proteins 0.000 description 1
102100026197 C-type lectin domain family 2 member D Human genes 0.000 description 1
108700012434 CCL3 Proteins 0.000 description 1
108010041397 CD4 Antigens Proteins 0.000 description 1
108010029697 CD40 Ligand Proteins 0.000 description 1
102100032937 CD40 ligand Human genes 0.000 description 1
102100035793 CD83 antigen Human genes 0.000 description 1
102100037904 CD9 antigen Human genes 0.000 description 1
108090000835 CX3C Chemokine Receptor 1 Proteins 0.000 description 1
102100039196 CX3C chemokine receptor 1 Human genes 0.000 description 1
108010061299 CXCR4 Receptors Proteins 0.000 description 1
102000012000 CXCR4 Receptors Human genes 0.000 description 1
102000000905 Cadherin Human genes 0.000 description 1
108050007957 Cadherin Proteins 0.000 description 1
102000016362 Catenins Human genes 0.000 description 1
108010067316 Catenins Proteins 0.000 description 1
108010083701 Chemokine CCL22 Proteins 0.000 description 1
102000006433 Chemokine CCL22 Human genes 0.000 description 1
102000000013 Chemokine CCL3 Human genes 0.000 description 1
108010014414 Chemokine CXCL2 Proteins 0.000 description 1
102000016951 Chemokine CXCL2 Human genes 0.000 description 1
102000009410 Chemokine receptor Human genes 0.000 description 1
108050000299 Chemokine receptor Proteins 0.000 description 1
108010049207 Death Domain Receptors Proteins 0.000 description 1
102000009058 Death Domain Receptors Human genes 0.000 description 1
101000802895 Dendroaspis angusticeps Fasciculin-1 Proteins 0.000 description 1
102100026693 FAS-associated death domain protein Human genes 0.000 description 1
229920001917 Ficoll Polymers 0.000 description 1
240000008168 Ficus benjamina Species 0.000 description 1
102000003964 Histone deacetylase Human genes 0.000 description 1
108090000353 Histone deacetylase Proteins 0.000 description 1
241000282412 Homo Species 0.000 description 1
101000964898 Homo sapiens 14-3-3 protein zeta/delta Proteins 0.000 description 1
101000799712 Homo sapiens Adenosine receptor A1 Proteins 0.000 description 1
101000971234 Homo sapiens B-cell lymphoma 6 protein Proteins 0.000 description 1
101000777599 Homo sapiens C-C chemokine receptor type 2 Proteins 0.000 description 1
101000858088 Homo sapiens C-X-C motif chemokine 10 Proteins 0.000 description 1
101000912615 Homo sapiens C-type lectin domain family 2 member D Proteins 0.000 description 1
101000946856 Homo sapiens CD83 antigen Proteins 0.000 description 1
101000911074 Homo sapiens FAS-associated death domain protein Proteins 0.000 description 1
101001006892 Homo sapiens Krueppel-like factor 10 Proteins 0.000 description 1
101000984186 Homo sapiens Leukocyte immunoglobulin-like receptor subfamily B member 4 Proteins 0.000 description 1
101001047640 Homo sapiens Linker for activation of T-cells family member 1 Proteins 0.000 description 1
101001054921 Homo sapiens Lymphatic vessel endothelial hyaluronic acid receptor 1 Proteins 0.000 description 1
101000760817 Homo sapiens Macrophage-capping protein Proteins 0.000 description 1
101001052493 Homo sapiens Mitogen-activated protein kinase 1 Proteins 0.000 description 1
101001097889 Homo sapiens Platelet-activating factor acetylhydrolase Proteins 0.000 description 1
101000837163 Homo sapiens Prostaglandin E synthase 3 Proteins 0.000 description 1
101001117519 Homo sapiens Prostaglandin E2 receptor EP2 subtype Proteins 0.000 description 1
101000909811 Homo sapiens Protein cornichon homolog 2 Proteins 0.000 description 1
101900082162 Human immunodeficiency virus type 1 group M subtype B Surface protein gp120 Proteins 0.000 description 1
238000012404 In vitro experiment Methods 0.000 description 1
102000003746 Insulin Receptor Human genes 0.000 description 1
108010001127 Insulin Receptor Proteins 0.000 description 1
102000014150 Interferons Human genes 0.000 description 1
108010050904 Interferons Proteins 0.000 description 1
102000000589 Interleukin-1 Human genes 0.000 description 1
108010002352 Interleukin-1 Proteins 0.000 description 1
108090001005 Interleukin-6 Proteins 0.000 description 1
102000004889 Interleukin-6 Human genes 0.000 description 1
102100027798 Krueppel-like factor 10 Human genes 0.000 description 1
102100025578 Leukocyte immunoglobulin-like receptor subfamily B member 4 Human genes 0.000 description 1
241000239218 Limulus Species 0.000 description 1
102100024032 Linker for activation of T-cells family member 1 Human genes 0.000 description 1
102100026849 Lymphatic vessel endothelial hyaluronic acid receptor 1 Human genes 0.000 description 1
206010025323 Lymphomas Diseases 0.000 description 1
102100025354 Macrophage mannose receptor 1 Human genes 0.000 description 1
102100024573 Macrophage-capping protein Human genes 0.000 description 1
102000018697 Membrane Proteins Human genes 0.000 description 1
108010052285 Membrane Proteins Proteins 0.000 description 1
208000026680 Metabolic Brain disease Diseases 0.000 description 1
208000001145 Metabolic Syndrome Diseases 0.000 description 1
206010062190 Metabolic encephalopathy Diseases 0.000 description 1
108700027654 Mitogen-Activated Protein Kinase 10 Proteins 0.000 description 1
102100024193 Mitogen-activated protein kinase 1 Human genes 0.000 description 1
102100026931 Mitogen-activated protein kinase 10 Human genes 0.000 description 1
241000581002 Murex Species 0.000 description 1
241000699670 Mus sp. Species 0.000 description 1
241000186359 Mycobacterium Species 0.000 description 1
239000004677 Nylon Substances 0.000 description 1
208000008589 Obesity Diseases 0.000 description 1
208000001388 Opportunistic Infections Diseases 0.000 description 1
108091000080 Phosphotransferase Proteins 0.000 description 1
241000701370 Plasmavirus Species 0.000 description 1
102100024448 Prostaglandin E2 receptor EP2 subtype Human genes 0.000 description 1
102100032258 Prostaglandin reductase 1 Human genes 0.000 description 1
102100024446 Protein cornichon homolog 2 Human genes 0.000 description 1
108091030071 RNAI Proteins 0.000 description 1
239000012979 RPMI medium Substances 0.000 description 1
241000700159 Rattus Species 0.000 description 1
102100038246 Retinol-binding protein 4 Human genes 0.000 description 1
101710137011 Retinol-binding protein 4 Proteins 0.000 description 1
108010003723 Single-Domain Antibodies Proteins 0.000 description 1
102000004584 Somatomedin Receptors Human genes 0.000 description 1
108010017622 Somatomedin Receptors Proteins 0.000 description 1
230000033540 T cell apoptotic process Effects 0.000 description 1
108090000925 TNF receptor-associated factor 2 Proteins 0.000 description 1
102100034779 TRAF family member-associated NF-kappa-B activator Human genes 0.000 description 1
102000000852 Tumor Necrosis Factor-alpha Human genes 0.000 description 1
102100040247 Tumor necrosis factor Human genes 0.000 description 1
102100033732 Tumor necrosis factor receptor superfamily member 1A Human genes 0.000 description 1
101710187743 Tumor necrosis factor receptor superfamily member 1A Proteins 0.000 description 1
108091000117 Tyrosine 3-Monooxygenase Proteins 0.000 description 1
102000048218 Tyrosine 3-monooxygenases Human genes 0.000 description 1
HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
201000000690 abdominal obesity-metabolic syndrome Diseases 0.000 description 1
230000003213 activating effect Effects 0.000 description 1
150000001413 amino acids Chemical group 0.000 description 1
210000003425 amniotic epithelial cell Anatomy 0.000 description 1
210000003484 anatomy Anatomy 0.000 description 1
238000000137 annealing Methods 0.000 description 1
210000000612 antigen-presenting cell Anatomy 0.000 description 1
239000002246 antineoplastic agent Substances 0.000 description 1
238000011225 antiretroviral therapy Methods 0.000 description 1
230000001640 apoptogenic effect Effects 0.000 description 1
230000005775 apoptotic pathway Effects 0.000 description 1
210000001130 astrocyte Anatomy 0.000 description 1
230000003115 biocidal effect Effects 0.000 description 1
230000005540 biological transmission Effects 0.000 description 1
230000000981 bystander Effects 0.000 description 1
230000015556 catabolic process Effects 0.000 description 1
238000004113 cell culture Methods 0.000 description 1
230000030833 cell death Effects 0.000 description 1
230000011748 cell maturation Effects 0.000 description 1
230000001413 cellular effect Effects 0.000 description 1
230000007969 cellular immunity Effects 0.000 description 1
230000004640 cellular pathway Effects 0.000 description 1
230000033077 cellular process Effects 0.000 description 1
238000012512 characterization method Methods 0.000 description 1
239000007795 chemical reaction product Substances 0.000 description 1
239000002975 chemoattractant Substances 0.000 description 1
OJYGBLRPYBAHRT-IPQSZEQASA-N chloralose Chemical compound O1[C@H](C(Cl)(Cl)Cl)O[C@@H]2[C@@H](O)[C@@H]([C@H](O)CO)O[C@@H]21 OJYGBLRPYBAHRT-IPQSZEQASA-N 0.000 description 1
238000010367 cloning Methods 0.000 description 1
239000013068 control sample Substances 0.000 description 1
230000008878 coupling Effects 0.000 description 1
238000010168 coupling process Methods 0.000 description 1
238000005859 coupling reaction Methods 0.000 description 1
238000004132 cross linking Methods 0.000 description 1
210000000805 cytoplasm Anatomy 0.000 description 1
238000007418 data mining Methods 0.000 description 1
230000003247 decreasing effect Effects 0.000 description 1
238000006731 degradation reaction Methods 0.000 description 1
238000004925 denaturation Methods 0.000 description 1
230000036425 denaturation Effects 0.000 description 1
238000013461 design Methods 0.000 description 1
238000002405 diagnostic procedure Methods 0.000 description 1
239000012636 effector Substances 0.000 description 1
230000008030 elimination Effects 0.000 description 1
238000003379 elimination reaction Methods 0.000 description 1
210000002472 endoplasmic reticulum Anatomy 0.000 description 1
108010072542 endotoxin binding proteins Proteins 0.000 description 1
210000002919 epithelial cell Anatomy 0.000 description 1
210000000981 epithelium Anatomy 0.000 description 1
238000011156 evaluation Methods 0.000 description 1
238000010195 expression analysis Methods 0.000 description 1
238000000605 extraction Methods 0.000 description 1
239000012091 fetal bovine serum Substances 0.000 description 1
210000002950 fibroblast Anatomy 0.000 description 1
238000001914 filtration Methods 0.000 description 1
238000000684 flow cytometry Methods 0.000 description 1
108091006047 fluorescent proteins Proteins 0.000 description 1
102000034287 fluorescent proteins Human genes 0.000 description 1
125000000524 functional group Chemical group 0.000 description 1
108020001507 fusion proteins Proteins 0.000 description 1
102000037865 fusion proteins Human genes 0.000 description 1
230000009368 gene silencing by RNA Effects 0.000 description 1
102000006602 glyceraldehyde-3-phosphate dehydrogenase Human genes 0.000 description 1
102000000418 human nicotinamide phosphoribosyltransferase Human genes 0.000 description 1
230000037417 hyperactivation Effects 0.000 description 1
230000002519 immonomodulatory effect Effects 0.000 description 1
230000002163 immunogen Effects 0.000 description 1
238000010874 in vitro model Methods 0.000 description 1
230000000415 inactivating effect Effects 0.000 description 1
238000011534 incubation Methods 0.000 description 1
230000006882 induction of apoptosis Effects 0.000 description 1
229940079322 interferon Drugs 0.000 description 1
102000014909 interleukin-1 receptor activity proteins Human genes 0.000 description 1
108040006732 interleukin-1 receptor activity proteins Proteins 0.000 description 1
230000003834 intracellular effect Effects 0.000 description 1
238000012417 linear regression Methods 0.000 description 1
230000004576 lipid-binding Effects 0.000 description 1
230000022288 lymphocyte chemotaxis Effects 0.000 description 1
238000004519 manufacturing process Methods 0.000 description 1
239000000463 material Substances 0.000 description 1
230000007246 mechanism Effects 0.000 description 1
230000004060 metabolic process Effects 0.000 description 1
238000012775 microarray technology Methods 0.000 description 1
230000026326 mitochondrial transport Effects 0.000 description 1
210000002864 mononuclear phagocyte Anatomy 0.000 description 1
238000010172 mouse model Methods 0.000 description 1
239000013642 negative control Substances 0.000 description 1
210000002569 neuron Anatomy 0.000 description 1
230000009223 neuronal apoptosis Effects 0.000 description 1
210000000440 neutrophil Anatomy 0.000 description 1
230000031972 neutrophil apoptotic process Effects 0.000 description 1
230000012223 nuclear import Effects 0.000 description 1
229920001778 nylon Polymers 0.000 description 1
235000020824 obesity Nutrition 0.000 description 1
244000052769 pathogen Species 0.000 description 1
230000008506 pathogenesis Effects 0.000 description 1
230000001717 pathogenic effect Effects 0.000 description 1
238000003068 pathway analysis Methods 0.000 description 1
230000002085 persistent effect Effects 0.000 description 1
208000025712 phagocytic cell dysfunction Diseases 0.000 description 1
230000026731 phosphorylation Effects 0.000 description 1
238000006366 phosphorylation reaction Methods 0.000 description 1
102000020233 phosphotransferase Human genes 0.000 description 1
230000036470 plasma concentration Effects 0.000 description 1
239000013641 positive control Substances 0.000 description 1
230000016833 positive regulation of signal transduction Effects 0.000 description 1
230000002064 post-exposure prophylaxis Effects 0.000 description 1
238000004321 preservation Methods 0.000 description 1
238000012545 processing Methods 0.000 description 1
102000003998 progesterone receptors Human genes 0.000 description 1
108090000468 progesterone receptors Proteins 0.000 description 1
VYXXMAGSIYIYGD-NWAYQTQBSA-N propan-2-yl 2-[[[(2R)-1-(6-aminopurin-9-yl)propan-2-yl]oxymethyl-(pyrimidine-4-carbonylamino)phosphoryl]amino]-2-methylpropanoate Chemical compound CC(C)OC(=O)C(C)(C)NP(=O)(CO[C@H](C)Cn1cnc2c(N)ncnc12)NC(=O)c1ccncn1 VYXXMAGSIYIYGD-NWAYQTQBSA-N 0.000 description 1
238000011002 quantification Methods 0.000 description 1
230000007115 recruitment Effects 0.000 description 1
238000011160 research Methods 0.000 description 1
229940064914 retrovir Drugs 0.000 description 1
238000010839 reverse transcription Methods 0.000 description 1
238000012552 review Methods 0.000 description 1
239000003419 rna directed dna polymerase inhibitor Substances 0.000 description 1
238000012216 screening Methods 0.000 description 1
230000009291 secondary effect Effects 0.000 description 1
230000028327 secretion Effects 0.000 description 1
230000011218 segmentation Effects 0.000 description 1
238000000926 separation method Methods 0.000 description 1
230000001568 sexual effect Effects 0.000 description 1
YEENEYXBHNNNGV-XEHWZWQGSA-M sodium;3-acetamido-5-[acetyl(methyl)amino]-2,4,6-triiodobenzoate;(2r,3r,4s,5s,6r)-2-[(2r,3s,4s,5r)-3,4-dihydroxy-2,5-bis(hydroxymethyl)oxolan-2-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound [Na+].CC(=O)N(C)C1=C(I)C(NC(C)=O)=C(I)C(C([O-])=O)=C1I.O[C@H]1[C@H](O)[C@@H](CO)O[C@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 YEENEYXBHNNNGV-XEHWZWQGSA-M 0.000 description 1
230000000638 stimulation Effects 0.000 description 1
238000013517 stratification Methods 0.000 description 1
239000000126 substance Substances 0.000 description 1
230000001629 suppression Effects 0.000 description 1
208000010648 susceptibility to HIV infection Diseases 0.000 description 1
210000001519 tissue Anatomy 0.000 description 1
230000002103 transcriptional effect Effects 0.000 description 1
241000701161 unidentified adenovirus Species 0.000 description 1
210000004509 vascular smooth muscle cell Anatomy 0.000 description 1
238000012795 verification Methods 0.000 description 1
210000000605 viral structure Anatomy 0.000 description 1
210000002845 virion Anatomy 0.000 description 1
230000003442 weekly effect Effects 0.000 description 1
238000001262 western blot Methods 0.000 description 1
HBOMLICNUCNMMY-XLPZGREQSA-N zidovudine Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](CO)[C@@H](N=[N+]=[N-])C1 HBOMLICNUCNMMY-XLPZGREQSA-N 0.000 description 1
239000011701 zinc Substances 0.000 description 1
229910052725 zinc Inorganic materials 0.000 description 1

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56966—Animal cells
- G01N33/56972—White blood cells
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56983—Viruses
- G01N33/56988—HIV or HTLV
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Immunology (AREA)
Hematology (AREA)
Molecular Biology (AREA)
Urology & Nephrology (AREA)
Biomedical Technology (AREA)
Analytical Chemistry (AREA)
Cell Biology (AREA)
Virology (AREA)
Physics & Mathematics (AREA)
Biotechnology (AREA)
Organic Chemistry (AREA)
Pathology (AREA)
Zoology (AREA)
Biochemistry (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Microbiology (AREA)
General Health & Medical Sciences (AREA)
Tropical Medicine & Parasitology (AREA)
Wood Science & Technology (AREA)
Genetics & Genomics (AREA)
Food Science & Technology (AREA)
Medicinal Chemistry (AREA)
General Physics & Mathematics (AREA)
Biophysics (AREA)
General Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
AIDS & HIV (AREA)
Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

CA002689131A 2007-06-08 2008-06-05 La nouvelle adipocytokine visfatine/pbef1 est un facteur associe a l'apoptose induit dans les monocytes pendant une infection du vih-i in vivo Abandoned CA2689131A1 (fr)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US93377407P	2007-06-08	2007-06-08
US60/933,774		2007-06-08
PCT/EP2008/057025 WO2008148858A1 (fr)	2007-06-08	2008-06-05	La nouvelle adipocytokine visfatine/pbef1 est un facteur associé à l'apoptose induit dans les monocytes pendant une infection du vih-i in vivo

Publications (1)

Publication Number	Publication Date
CA2689131A1 true CA2689131A1 (fr)	2008-12-11

Family

ID=39730670

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
CA002689131A Abandoned CA2689131A1 (fr)	2007-06-08	2008-06-05	La nouvelle adipocytokine visfatine/pbef1 est un facteur associe a l'apoptose induit dans les monocytes pendant une infection du vih-i in vivo

Country Status (4)

Country	Link
US (1)	US20100184031A1 (fr)
EP (1)	EP2164983A1 (fr)
CA (1)	CA2689131A1 (fr)
WO (1)	WO2008148858A1 (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
KR20190030779A (ko)	2008-01-18	2019-03-22	프레지던트 앤드 펠로우즈 오브 하바드 칼리지	체액 내에서 질병 또는 병태의 시그너쳐의 검출 방법
WO2012012717A1 (fr)	2010-07-23	2012-01-26	President And Fellows Of Harvard College	Méthodes de dépistage de maladies ou d'affections prénatales ou liées à la grossesse
WO2012012694A2 (fr)	2010-07-23	2012-01-26	President And Fellows Of Harvard College	Procédés de détection de maladies/pathologies auto-immunes ou liées au système immunitaire
BR112013001752A2 (pt) *	2010-07-23	2016-05-31	Harvard College	método de detectar doenças ou condições usando células fagocídicas
EP2965077B1 (fr)	2013-03-09	2022-07-13	Harry Stylli	Procédés de détection de cancer
WO2017041114A2 (fr) *	2015-09-03	2017-03-09	The Children's Mercy Hospital	Gènes d'anticorps anti-nicotinamide phosphoribosyltransférase et leurs procédés d'utilisation
WO2025098496A1 (fr) *	2023-11-10	2025-05-15	The University Of Hong Kong	Composition pharmaceutique et méthodes de traitement d'une infection par le vih-1

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20070202515A1 (en) *	2005-10-12	2007-08-30	Pathologica, Llc.	Promac signature application

2008
- 2008-06-05 WO PCT/EP2008/057025 patent/WO2008148858A1/fr not_active Ceased
- 2008-06-05 US US12/451,864 patent/US20100184031A1/en not_active Abandoned
- 2008-06-05 CA CA002689131A patent/CA2689131A1/fr not_active Abandoned
- 2008-06-05 EP EP08760600A patent/EP2164983A1/fr not_active Withdrawn

Also Published As

Publication number	Publication date
EP2164983A1 (fr)	2010-03-24
WO2008148858A1 (fr)	2008-12-11
US20100184031A1 (en)	2010-07-22

Publication	Publication Date	Title
Durand et al.	2012	HIV-1 DNA is detected in bone marrow populations containing CD4+ T cells but is not found in purified CD34+ hematopoietic progenitor cells in most patients on antiretroviral therapy
Peng et al.	2012	An effector phenotype of CD8+ T cells at the junction epithelium during clinical quiescence of herpes simplex virus 2 infection
Giri et al.	2009	Circulating monocytes in HIV-1-infected viremic subjects exhibit an antiapoptosis gene signature and virus-and host-mediated apoptosis resistance
Hoffman et al.	1997	CCR5 genotypes in sexually active couples discordant for human immunodeficiency virus type 1 infection status
Hishizawa et al.	2004	Depletion and impaired interferon‐α‐producing capacity of blood plasmacytoid dendritic cells in human T‐cell leukaemia virus type I‐infected individuals
US20100184031A1 (en)	2010-07-22	Novel adipocytokine visfatin/pbef1 is an apoptosis associated factor induced in monocytes during in vivo hiv-1 infection
Van den Bergh et al.	2010	Transcriptome analysis of monocyte-HIV interactions
Congy-Jolivet et al.	2022	Monocytes are the main source of STING-mediated IFN-α production
Monteleone et al.	2014	Interleukin-32 isoforms: expression, interaction with interferon-regulated genes and clinical significance in chronically HIV-1-infected patients
Xu et al.	2006	Expression of Toll-like receptors and their association with cytokine responses in peripheral blood mononuclear cells of children with acute rotavirus diarrhoea
Imbeault et al.	2009	Microarray study reveals that HIV-1 induces rapid type-I interferon-dependent p53 mRNA up-regulation in human primary CD4+ T cells
Thomas et al.	2014	Differential responses of plasmacytoid dendritic cells to influenza virus and distinct viral pathogens
Wallace et al.	2020	Canonical Wnts mediate CD8+ T cell noncytolytic anti–HIV-1 activity and correlate with HIV-1 clinical status
Hoffmann et al.	2023	Unique molecular signatures sustained in circulating monocytes and regulatory T cells in convalescent COVID-19 patients
Leal et al.	2018	Comprehensive antiretroviral restriction factor profiling reveals the evolutionary imprint of the ex vivo and in vivo IFN-β response in HTLV-1-associated neuroinflammation
Dye et al.	2019	Comparative DNA methylomic analyses reveal potential origins of novel epigenetic biomarkers of insulin resistance in monocytes from virally suppressed HIV-infected adults
US20220196677A1 (en)	2022-06-23	Kits, compositions and methods for evaluating immune system status
Hashimoto et al.	2015	Fibrocytes differ from macrophages but can be infected with HIV-1
Barmada et al.	2024	Single‐cell multi‐omics analysis of COVID‐19 patients with pre‐existing autoimmune diseases shows aberrant immune responses to infection
Pinto et al.	2014	Genes related to antiviral activity, cell migration, and lysis are differentially expressed in CD4+ T cells in human T Cell leukemia virus type 1-associated myelopathy/tropical spastic paraparesis patients
Vanderheiden et al.	2021	CCR2-dependent monocyte-derived cells restrict SARS-CoV-2 infection
Rahmberg et al.	2017	Dynamic modulation of expression of lentiviral restriction factors in primary CD4+ T cells following simian immunodeficiency virus infection
Dong et al.	2022	Memory cytotoxic SARS-CoV-2 spike protein-specific CD4+ T cells associate with viral control
McLaren et al.	2004	Antigen-specific gene expression profiles of peripheral blood mononuclear cells do not reflect those of T-lymphocyte subsets
EP3634405A1 (fr)	2020-04-15	Procédés de détection de dysbiose et de traitement de sujets atteints d'une dysbiose

Legal Events

Date	Code	Title	Description
2013-07-31	FZDE	Dead	Effective date: 20130605